Envision Pharma Group
Alice will lead the organization's IMC division made up of experts in medical strategy, medical communications, publications planning and delivery, patient engagement, and more to deliver smarter, faster outcomes for life sciences clients.
HORSHAM, UK / ACCESSWIRE / January 16, 2024 / Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) and a member of its Executive Leadership Team. In her new role, Alice will lead the organization's IMC division made up of experts in medical strategy, medical communications, publications planning and delivery, patient engagement, and more to deliver smarter, faster outcomes for life sciences clients.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page."I am so pleased to welcome Alice to the Envision team and her invaluable experience as a global life sciences industry leader," shares Howard Miller, CEO of Envision Pharma Group. "Alice brings a depth of strategic expertise, knowledge, and insight in the medical communications, scientific research, and publications field that will be instrumental in propelling our vision forward for our people and serving the needs of our clients."
Alice joins Envision from IPG Health where she most recently served as EVP, Managing Director, Client Solutions, APAC. Prior to this, the bulk of her career was in IPG Health Medical Communications - latterly as Chief Operating Officer for the group and formerly, as Head of Complete Medical Communications. During her tenure, she played a pivotal role in establishing and fulfilling long-term business goals while focusing on building upon key client relationships to foster sustained business growth, development, and operational excellence across several global teams.
Alice is committed to best practices and standards in medical communications, as demonstrated in her current role as Chair of the Healthcare Communications Association and through her success at IPG Health Medical Communications and former tenure as Chair of the International Society of Medical Publications Professionals (ISMPP).
Alice adds, "I have long admired the work done by Envision and am excited to be joining such a stellar team. Medical communications continue to move at a rapid pace, and I look forward to ensuring that we continue leading the field in terms of our people, our quality, and our innovative patient-centric services."
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including 19 of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include artificial intelligence and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at www.envisionpharmagroup.com.
Contact Information
Colleen Carter
Associate Director, Communications, Office of CEO
colleen.carter@envisionpharma.com
1 (508) 505 8856
SOURCE: Envision Pharma Group
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Polaris Renewable Energy Announces Corporate and Bond Instrument Credit Rating8.11.2024 12:05:00 CET | Press release
TORONTO, ON / ACCESSWIRE / November 8, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") is pleased to announce that international credit rating agency S&P Global Ratings has assigned corporate credit and bond instrument ratings of BB- with Stable Outlook to Polaris. About Polaris Renewable Energy Inc. Polaris Renewable Energy Inc. is a Canadian publicly traded company engaged in the development, construction, acquisition, and operation of renewable energy projects in five countries in Latin America and the Caribbean. The Company's operations include a geothermal plant (~82 MW), four run-of river hydroelectric plants (~40 MW), three solar (photovoltaic) projects in operation (~35 MW) and one wind park (26 MW) following closing of the Puerto Rico acquisition. For more information, contact: Investor Relations Polaris Renewable Energy Inc. Phone: +1 647-245-7199 Email: info@PolarisREI.com SOURCE: Polaris Renewable Energy Inc. View the original press release on ac
MANAMAURI, the High-Quality Energy Drink Brand, Joins EastBridge Global Investments for Major International Expansion8.11.2024 10:00:00 CET | Press release
The acquisition will fuel Manamauri's global expansion with new production facilities, extended product lines, and a continued commitment to supporting emerging sports. BRUSSELS, BELGIUM / ACCESSWIRE / November 8, 2024 / MANAMAURI, the energy drink brand known for its commitment to high quality and smart pricing, has officially finalized an acquisition agreement with a subsidiary of EastBridge Global Investments. This strategic partnership empowers MANAMAURI to scale globally, remaining true to its founding values of exceptional product standards, accessibility, and support for emerging sports talent. MANAMAURI LOGO MANAMAURI LOGO "MANAMAURI was established with a clear mission: to deliver premium energy products with an intelligent pricing model, making quality accessible without compromising our values," shared a spokesperson for MANAMAURI. "We've managed to grow steadily while maintaining lean operations, focusing on efficient structures that keep unnecessary costs low. The success
Greene Tweed Awarded 'Excellence in International Trade' at the 2024 East Midlands Chamber Business Awards8.11.2024 03:00:00 CET | Press release
The regional accolade recognizes commitment to global expansion and customer support LANSDALE, PA / ACCESSWIRE / November 8, 2024 / Greene Tweed, a global leader in advanced materials and high-performance solutions, has been honored as the Nottinghamshire "Excellence in International Trade" recipient of the 2024 East Midlands Chamber Business Awards, which celebrate the achievement and resilience of companies throughout the region. The East Midlands Chamber plays a vital role in connecting, supporting, and championing businesses and communities across Derbyshire, Leicestershire and Nottinghamshire in the United Kingdom. The Nottinghamshire Business Awards recently celebrated outstanding achievements in the local business community, where winners across 13 categories were announced. The "Excellence in International Trade" award specifically recognizes local businesses that excel in overseas trade. As one of five finalists in the category, Greene Tweed was selected for its robust growth
Polaris Renewable Energy Announces Fixed Income Meetings8.11.2024 01:00:00 CET | Press release
TORONTO, ON / ACCESSWIRE / November 8, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") announces today that it has engaged Pareto Securities as lead manager to arrange a series of fixed income meetings with potential eligible investors. Subject to market conditions and acceptable terms, the Company may issue a rated five-year tenor green bond on a private placement basis. The use of proceeds would be used to refinance certain existing debt facilities, the acquisition of the Punta Lima wind farm in Puerto Rico and other investments in renewable energy assets. S&P Global Ratings is expected to provide corporate and instrument ratings. The contemplated bond would be issued under the Company's green finance framework with second-party opinion from Morningstar Sustainalytics. The bonds have not been and will not be qualified for distribution in any province or territory of Canada. Accordingly, the bonds may not be offered or sold within any such province or terri
Innodata Reports Third Quarter 2024 Results; Record 136% Revenue Growth Year-Over-Year7.11.2024 17:00:00 CET | Press release
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / INNODATA INC. (Nasdaq: INOD) today reported results for the third quarter ended September 30, 2024. Revenue of $52.2 million, 136% revenue growth year-over-year. Net income of $17.4 million, or $0.60 per basic share and $0.51 per diluted share, compared to net income of $0.4 million, or $0.01 per basic and diluted share, in the same period last year. Third quarter net income included a $5.6 million benefit as a result of recognizing a deferred tax asset that related to our accumulated net operating losses and other deferred expenses from prior periods. Adjusted EBITDA of $13.9 million, an increase of 337% from $3.2 million in the same period last year.* Cash, cash equivalents and short-term investments of $26.4 million at September 30, 2024 and $13.8 million at December 31, 2023. Guidance raised to between 88% and 92% year-over-year revenue growth for full year 2024. *Adjusted EBITDA is defined below. Jack Abuhoff, CEO, said "Innodata cont
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom